DrugDashboards

Market view

dobutamine hydrochloride · Injection

4 marketed package NDCs · 2 active manufacturers

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now.

Same drug class

Other molecules FDA puts in beta-Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Dobutamine hydrochloride in shortage right now?
Yes. FDA currently lists Dobutamine hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database.
Who makes Dobutamine hydrochloride?
3 companies have marketed Dobutamine hydrochloride in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • In shortage nowDobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02)Nov 6, 2017
  • In shortage nowDobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02)Nov 6, 2017
  • In shortage nowDobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02)Nov 6, 2017

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.